Patient Adherence Program Design

Not Found

Sorry, but no results were found. Please use our navigation or search to find what you are looking for.

Do you believe there are sufficient treatment options for HIV to warrant formulary exclusions?

Yes: 75%

No: 25%

Do you believe there are sufficient treatment options for Hemophilia to warrant formulary exclusions?

Yes: 71%

No: 29%

Do you believe there are sufficient treatment options for Hereditary Angioedema to warrant formulary exclusions?

Yes: 17%

No: 83%

How will state regulation and licensure of PBMs impact retail pharmacies? (select all that apply)

Improve pharmacy reimbursement rates: 5.88%

Add transparency to Rx reimbursement: 35.29%

Reduce PBM conflict of interests: 17.65%

Eliminate retrospective financial clawbacks: 17.65%

No impact: 11.76%

Reduce pharmacy reimbursement rates: 11.76%

How will the addition of step therapy on Medicare Part B drugs impact biosimilars?

Increase use of biosimilars: 54.55%

No Change: 36.36%

Decrease biosimilar use: 9.09%